Non-small cell lung cancers
Clinical trials for Non-small cell lung cancers explained in plain language.
Never miss a new study
Get alerted when new Non-small cell lung cancers trials appear
Sign up with your email to follow new studies for Non-small cell lung cancers, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer combo trial ends before it begins: only one patient enrolled
Disease control Stopped earlyThis early-phase trial aimed to test the safety of combining two drugs, adagrasib and olaparib, in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The study planned to include patients with certain breast, ovarian, pancreatic, and lung canc…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising combo for rare cancer mutation stalls as study ends early
Disease control Stopped earlyThis early-phase study tested a new drug called PRT3789 combined with the immunotherapy pembrolizumab (Keytruda) in people with advanced solid tumors that have a SMARCA4 gene mutation. The goal was to see if the combination was safe and could shrink tumors. However, the study was…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase 2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC